Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on October 6, 2026

Oct. 6, 2026

Odyssey Therapeutics Announces Oral Presentation of Additional Phase 2a Induction Data for OD-001 in Ulcerative Colitis at UEG Week 2026

Indeterminate GlobeNewswire

Oct. 6, 2026

authID Announces $2 Million Agreement with the EinStrong Foundation

Indeterminate GlobeNewswire

Oct. 6, 2026

Rezolve Ai Showcases Agentic Commerce Platform at Nasdaq Investor Day and Publishes U.S. AI Visibility Study

Indeterminate GlobeNewswire

Oct. 6, 2026

Madrigal Announces Publication in the Journal of Hepatology Demonstrating Consistent Rezdiffra Efficacy Across Common MASH Genetic Risk Variants

Indeterminate GlobeNewswire

Oct. 6, 2026

Tango Communities Go Live for Breast Cancer Research

Indeterminate GlobeNewswire

Oct. 6, 2026

ArriVent Announces Program Update from the Phase 3 FURVENT Trial of Firmonertinib in First-Line EGFR Exon 20 Insertion Mutant NSCLC

Indeterminate GlobeNewswire

Oct. 6, 2026

SalesCloser Launches Sky: Businesses Now Build a Live AI Sales Agent in Minutes, Just by Talking to It

Indeterminate GlobeNewswire

Oct. 6, 2026

The Hidden Toll of Frictionless Tech: What AI Does to Our Minds

Indeterminate GlobeNewswire

Oct. 6, 2026

ParaZero and ThirdEye Unveil New Battlefield System Designed to Detect and Intercept Drones for Armored Vehicles

Indeterminate GlobeNewswire

Oct. 6, 2026

BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting

Indeterminate GlobeNewswire

Oct. 6, 2026

SCYNEXIS Announces Phase 1 Study Results for SCY-770, a Novel, Highly Selective, Oral Direct AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Indeterminate GlobeNewswire

Oct. 6, 2026

Cerenome Launches CNSide® CSF Molecular Profile Tests

Indeterminate GlobeNewswire

Oct. 6, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for Oral Infigratinib for Children with Achondroplasia

Indeterminate GlobeNewswire

Oct. 6, 2026

ONAR Appoints Audit Chair Kelly Anderson, Former Public-Company CFO and Veteran of More Than 400 Acquisitions, as Interim Chief Financial Officer to Lead Nasdaq Uplist Preparation

Indeterminate GlobeNewswire

Oct. 6, 2026

NowVertical Group Announces Appointment of Andre Garber as CEO and an Up to $15.1 Million Brokered Private Placement of Units and Convertible Debenture Units

Indeterminate GlobeNewswire

Oct. 6, 2026

ProMIS Neurosciences Appoints Seasoned Alzheimer’s and Neuroscience Executive Ivana Rubino, Ph.D., as Chief Commercial Officer

Indeterminate GlobeNewswire

Oct. 6, 2026

Zenas BioPharma to Host Virtual R&D Event

Indeterminate GlobeNewswire

Oct. 6, 2026

Ocugen Appoints Industry Executive Jolanda Crombach General Manager of European Affiliate

Indeterminate GlobeNewswire

Oct. 6, 2026

Octave to Report Third Quarter 2026 Financial Results on November 12

Indeterminate GlobeNewswire

Oct. 6, 2026

LiveU and Airwise Announce Strategic Partnership to Deliver End-to-End Solution for Public Safety Situational Awareness

Indeterminate GlobeNewswire